News and Events

Check out all of our accomplishments in our CHP Newsletter! You can read about student awards, new grants, and opportunities for our graduate students and alumni. 


 Calendar of Upcoming Events:

June 17th - 20th - American Academy of Clinical Neuropsychology (AACN) 13th Annual Conference - San Francisco, California

August 1st- 3rd - 74th Annual Conference of the International Council of Psychologist - Toronto, Canada

August 6th-9th - 123rd Annual Convention of the American Psychological Association- Toronto, Canada

September 26th - Legislative Committee Meeting - New York

New Issue of APA's Monitor



CMSC Grant Awarded to Dr. Frederick Foley 

Frederick W. Foley, Ph.D., professor at the Ferkauf Graduate School of Psychology and clinical psychologist at Holy Name Medical Center, along with his students, Jessica Sloan and Elana Mendelowitz, were recently awarded a one-year pilot grant from the Consortium of Multiple Sclerosis Centers (CMSC) to conduct a randomized controlled trial of mindfulness-based cognitive therapy (MBCT) as a treatment for pain and depression in a Multiple Sclerosis (MS) population. Pain and depression are extremely prevalent symptoms in MS, frequently difficult to treat, and interfere with activities of daily living, employment status, and quality of life. This study thus has the potential to improve the lives of those with MS by utilizing a treatment approach that has been found to be helpful in alleviating pain and depression in non-MS populations. The MBCT groups will incorporate a four-week group intervention with components of both mindfulness and cognitive therapy, which have been shown to be helpful in MS populations in the past. MBCT groups will be compared to MS support groups, thus controlling for non-specific effects. This study will therefore investigate a novel approach to the treatment of pain and depression that has yet to be studied in an MS population and one that involves minimal risk, thus enhancing its potential benefit.


Accurate Asthma Assessment

Jonathan M. Feldman, Ph.D. has received $3 million from the National Heart, Lung, and Blood Institute to study whether training teenagers with athma to better recognize their symptoms can improve asthma control and reduce emergency health care use. Children who fail to correctly perceive the severity of their asthma symptoms have more emergency department visits, hospitalizations, and fatal or near-fatal asthma attacks. Puerto Rican and black children have higher rates of asthma complications and deaths than other racial/ethnic groups. Dr. Feldman hypothesizes that helping asthma patients better recognize symptoms may help close this asthma health disparities gap. A randomized controlled trial will examine whether a behavioral intervention to train adolescents to guess their peak expiratory flow improved the accuracy of symptom perception and adherence to controller medications for asthma. Dr. Feldman is clinical assistant professor in the department of pediatrics.

Five-year clinical trial funded by NIA (R01AG050448)

Roee Holtzer, Ph.D., professor and program director at the Ferkauf Graduate School of Psychology, and Dr. Joe Verghese, professor at Albert Einstein College of Medicine, were recently awarded funding for a five-year cinical trial from for a cognitive intervention to improve simple and complex walking. Ambulatory disabilities represent the most prevalent disability among US seniors. This ‘proof of concept’ clinical trial will fill an important gap in knowledge of the efficacy of cognitive remediation as a secondary prevention strategy to improve this debilitating condition. Demonstrating mobility gains through cognitive training will provide insight for future mobility treatment options, and if successful will establish an accessible and low-risk method to enhance mobility among frail sedentary seniors.